Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Amplia's Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
7-Sep-2022
Notification regarding unquoted securities - ATX
7-Sep-2022
Change of Director's Interest Notice - Dr. Warwick Tong
7-Sep-2022
Change of Director's Interest Notice - Dr. Robert Peach
7-Sep-2022
Change of Director's Interest Notice - Dr. Christopher Burns
7-Sep-2022
Change of Director's Interest Notice - Mrs. Jane Bell
6-Sep-2022
Change of Director's Interest Notice - Dr. John Lambert
2-Sep-2022
Notification of cessation of securities - ATX
31-Aug-2022
Amplia Receives $1.8m R&D Tax Incentive
25-Aug-2022
Results of Annual General Meeting
25-Aug-2022
CEO & Managing Director Presentation to AGM
Previous
1
2
3
4
5
6
Next
